AngioDynamics
This article was originally published in The Gray Sheet
Executive Summary
Company exits cardiovascular market Aug. 1 via sale of its AngioDynamics Ltd. interventional cardiology business to management, supported by the venture capital firms Alliance Investment Capital and ICC. The deal includes the division's Enniscorthy, Ireland manufacturing facility for electromechanical injectors and sterile, disposable devices. The move is in line with the parent firm's strategy to focus entirely on the interventional radiology market